PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsschizophrenia spectrum and other psychotic disorders
MeSH D019967 - schizophrenia spectrum and other psychotic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001523:Mental disorders
0 Companies
0 Drugs
Success rate
D019967: 
Schizophrenia spectrum and other psychotic disorders
D000341:Psychotic affective disorders
D002194:Capgras syndrome
0 Companies
0 Drugs
Success rate
D010259:Paranoid disorders
0 Companies
0 Drugs
Success rate
D011618:Psychotic disorders
D012559:Schizophrenia
D055535:Morgellons disease
0 Companies
0 Drugs
Success rate
D063726:Delusional parasitosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareAripiprazole Aripiprazole  2016-12-07   
Aripiprazole Aripiprazole Accord  2015-11-15   
Clozapine Clozapine  2015-11-25   
Quetiapine Quetiapine  2016-11-01   
Ajanta PharmaAripiprazole Aripiprazole  2016-09-12   
Olanzapine Olanzapine  2017-05-30   
Risperidone Risperidone  2011-08-24   
Paliperidone Paliperidone  2024-06-26   
Alembic PharmaceuticalsAripiprazole Aripiprazole  2015-04-28   
Asenapine Asenapine  2020-12-10   
Quetiapine Quetiapine  2014-10-28   
Paliperidone Paliperidone  2024-09-26   
Alkem LaboratoriesAripiprazole Aripiprazole  2019-02-21   
Olanzapine Olanzapine  2015-10-20   
Quetiapine Quetiapine  2013-02-12   
AlkermesAripiprazole lauroxil Aristada 2030-06-24 2015-10-05 $332.941 M Q4/23-Q3/24 
Olanzapine, Samidorphan Lybalvi 2025-11-23 2021-05-28 $259.273 M Q4/23-Q3/24 
AllerganAsenapine Saphris 2026-04-06 2009-08-13 $134.4 M Q2/19-Q1/20 
Haloperidol Haloperidol  1988-05-17   
Paliperidone Paliperidone  2015-08-03   
Quetiapine Quetiapine  2013-02-27   
Risperidone Risperidone  2011-04-19   
AlpharmaHaloperidol Haloperidol  1986-04-11   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
33%
2/6
Phase 3
100%
20/20
Approved: 20Overall Success rate: 22%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use